These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2911 related items for PubMed ID: 15770006

  • 1. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S, Swiss HIV Cohort.
    J Natl Cancer Inst; 2005 Mar 16; 97(6):425-32. PubMed ID: 15770006
    [Abstract] [Full Text] [Related]

  • 2. Cancer risk in people infected with human immunodeficiency virus in the United States.
    Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ.
    Int J Cancer; 2008 Jul 01; 123(1):187-94. PubMed ID: 18435450
    [Abstract] [Full Text] [Related]

  • 3. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
    Chaturvedi AK, Mbulaiteye SM, Engels EA.
    Ann Epidemiol; 2008 Mar 01; 18(3):230-4. PubMed ID: 18083545
    [Abstract] [Full Text] [Related]

  • 4. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
    Polesel J, Clifford GM, Rickenbach M, Dal Maso L, Battegay M, Bouchardy C, Furrer H, Hasse B, Levi F, Probst-Hensch NM, Schmid P, Franceschi S, Swiss HIV Cohort Study.
    AIDS; 2008 Jan 11; 22(2):301-6. PubMed ID: 18097233
    [Abstract] [Full Text] [Related]

  • 5. [Epidemiology of HIV-associated malignancies].
    Launay O, Guillevin L.
    Bull Cancer; 2003 May 11; 90(5):387-92. PubMed ID: 12850760
    [Abstract] [Full Text] [Related]

  • 6. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S, Gill MJ.
    HIV Med; 2006 Sep 11; 7(6):369-77. PubMed ID: 16903981
    [Abstract] [Full Text] [Related]

  • 7. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
    Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, Mandelia S, Møller H, Bower M.
    J Clin Oncol; 2009 Feb 20; 27(6):884-90. PubMed ID: 19114688
    [Abstract] [Full Text] [Related]

  • 8. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.
    Hessol NA, Pipkin S, Schwarcz S, Cress RD, Bacchetti P, Scheer S.
    Am J Epidemiol; 2007 May 15; 165(10):1143-53. PubMed ID: 17344204
    [Abstract] [Full Text] [Related]

  • 9. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.
    Arch Dermatol; 2007 Jan 15; 143(1):45-50. PubMed ID: 17224541
    [Abstract] [Full Text] [Related]

  • 10. Impact of HAART on HIV-linked malignancies.
    Laurence J.
    AIDS Read; 2003 May 15; 13(5):202, 205. PubMed ID: 12800820
    [No Abstract] [Full Text] [Related]

  • 11. A prevalence of posttransplantation cancers compared with cancers in people with human immunodeficiency virus/acquired immunodeficiency syndrome after highly active antiretroviral therapy.
    Srisawat N, Avihingsanon A, Praditpornsilpa K, Jiamjarasrangsi W, Eiam-Ong S, Avihingsanon Y.
    Transplant Proc; 2008 Oct 15; 40(8):2677-9. PubMed ID: 18929833
    [Abstract] [Full Text] [Related]

  • 12. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparén P, Tryggvadottir L, Weiderpass E, Kjaerheim K.
    Acta Oncol; 2009 Oct 15; 48(5):646-790. PubMed ID: 19925375
    [Abstract] [Full Text] [Related]

  • 13. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
    Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, Plaisance N, Tissot-Dupont H, Boue F, Lang JM, Costagliola D.
    J Clin Oncol; 2003 Sep 15; 21(18):3447-53. PubMed ID: 12972519
    [Abstract] [Full Text] [Related]

  • 14. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
    Calabresi A, Ferraresi A, Festa A, Scarcella C, Donato F, Vassallo F, Limina R, Castelli F, Quiros-Roldan E, Brescia HIV Cancer Study Group.
    HIV Med; 2013 Sep 15; 14(8):481-90. PubMed ID: 23560682
    [Abstract] [Full Text] [Related]

  • 15. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
    Bonnet F, Balestre E, Thiébaut R, Morlat P, Pellegrin JL, Neau D, Dabis F, Groupe d'Epidemiologie Clinique du SIDA en Aquitaine.
    Clin Infect Dis; 2006 Feb 01; 42(3):411-7. PubMed ID: 16392091
    [Abstract] [Full Text] [Related]

  • 16. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
    Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ.
    J Natl Cancer Inst; 2004 Jul 21; 96(14):1070-6. PubMed ID: 15265968
    [Abstract] [Full Text] [Related]

  • 17. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future.
    Engels EA, Goedert JJ.
    J Natl Cancer Inst; 2005 Mar 16; 97(6):407-9. PubMed ID: 15769998
    [No Abstract] [Full Text] [Related]

  • 18. Risk of cancer among women with AIDS in New York City.
    Fordyce EJ, Wang Z, Kahn AR, Gallagher BK, Merlos I, Ly S, Schymura M, Chiasson MA.
    AIDS Public Policy J; 2000 Mar 16; 15(3-4):95-104. PubMed ID: 12189715
    [Abstract] [Full Text] [Related]

  • 19. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
    Kaae J, Hansen AV, Biggar RJ, Boyd HA, Moore PS, Wohlfahrt J, Melbye M.
    J Natl Cancer Inst; 2010 Jun 02; 102(11):793-801. PubMed ID: 20424236
    [Abstract] [Full Text] [Related]

  • 20. Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals.
    Busnach G, Piselli P, Arbustini E, Baccarani U, Burra P, Carrieri MP, Citterio F, De Juli E, Bellelli S, Pradier C, Rezza G, Serraino D, Immunosuppression and Cancer Study Group.
    Transplant Proc; 2006 Dec 02; 38(10):3533-5. PubMed ID: 17175324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 146.